Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review - Report - MDSpire

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

  • By

  • Valeria Concha Fernández

  • Mariana González Garcés

  • Jerónimo Cárdenas Montoya

  • Mario Andrés Torres Torres

  • Erwin Hernando Hernández Rincón

  • May 28, 2026

  • 0 min

Share

Clinical Report: Novel Uses of Artificial Intelligence in Risk Assessment for Head and Neck Cancer

Overview

This scoping review identifies emerging applications of artificial intelligence (AI) in risk stratification for head and neck cancer, highlighting its potential to enhance diagnostic and prognostic accuracy. The findings underscore the need for methodological standardization and validation to ensure effective clinical implementation.

Background

Head and neck cancer poses significant challenges due to its biological and anatomical diversity, which complicates accurate risk assessment using conventional staging systems. The integration of AI into clinical practice could optimize diagnostic and therapeutic decision-making, ultimately leading to more personalized treatment approaches. Understanding the role of AI in this context is crucial for improving patient outcomes.

Data Highlights

A total of 44 studies were included, focusing on AI applications for diagnostic tasks and prognostic risk stratification in head and neck cancer.

Key Findings

  • AI techniques were primarily applied to predict lymph node metastasis and extranodal extension.
  • Machine learning models, deep learning architectures, and radiomics-based methods were the most frequently employed approaches.
  • Common data modalities included computed tomography, magnetic resonance imaging, and digital histopathology.
  • Studies reported moderate to high predictive performance, but exhibited substantial methodological heterogeneity.
  • There was a predominance of retrospective designs and limited external validation of AI models.

Clinical Implications

Clinicians should consider the integration of AI tools to enhance risk stratification and improve decision-making in head and neck cancer management. However, careful attention must be paid to the methodological rigor and validation of these AI models before widespread clinical adoption.

Conclusion

AI has the potential to significantly improve risk stratification in head and neck cancer, but challenges related to validation and implementation must be addressed to realize its full benefits in clinical practice.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Author(s)/Org, Source, Year -- Title
  6. NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
  7. Re-examining post-operative chemoradiotherapy in head and neck cancer
  8. Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial
  9. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial - PubMed
  10. Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer | Head and Neck Cancer | JAMA Oncology | JAMA Network
  11. Accuracy of Salivary Circulating Tumor Human Papillomavirus DNA in Detecting Oropharyngeal Cancer: A Systematic Review and Meta-Analysis - PubMed
  12. The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis | Journal of Experimental & Clinical Cancer Research | Springer Nature Link
  13. A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinoma - PubMed
  14. Artificial Intelligence for Head and Neck Squamous Cell Carcinoma: From Diagnosis to Treatment | American Society of Clinical Oncology Educational Book
  15. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods | The BMJ
  16. The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights - PubMed
  17. Frontiers | Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Original Source(s)

Related Content